Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 06
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Abbott Laboratories
ABT
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$100.10
2.60
2.67%
Últ. Act.: Oct 5, 7:54 PM
$100.59
3.09
3.17%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Privacy Manager
PRO
¿Por qué se mueve?:
Abbott shares are trading higher after the company received FDA approval fo...
Dividendo:
La fecha límite del dividendo es dentro de 10 días
Abbott Laboratories Financials
Abbott Laboratories (ABT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.
Avi Kapoor
Why Is Intuitive Surgical Stock Sinking Friday?
ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow U.S. procedure growth.
Lekha Gupta
Nasdaq Tumbles 1.5% Amid Selloff In Chip Stocks: Investor Sentiment Weakens, Greed Index Moves To ‘Fear’ Zone
Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and Abbott Laboratories reported strong earnings.
Avi Kapoor
Abbott Brushes Off Procedure Volume Concerns, Lifts Outlook
Abbott (ABT) stock jumps 12% after beating Q2 2026 earnings and revenue estimates and raising its full-year profit outlook. Read more.
Vandana Singh
PRO
Abbott Projects Full-Year 2026 Comparable Sales Growth Of 6.5% To 7.5%
Benzinga Newsdesk
PRO
Abbott Laboratories Sees Q3 Adj EPS $1.38-$1.46 vs $1.42 Est
Abbott Laboratories (NYSE:ABT) is looking for Q3 Adj EPS of $1.38-$1.46 vs $1.42 analyst estimate..
Benzinga Newsdesk
